Thomas Parr

Chief Scientific Officer at Spero Therapeutics

No bio yet


Org chart


Teams


Offices

This person is not in any offices


Spero Therapeutics

2 followers

Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.


Industries

Employees

51-200

Links